Kinetic analysis of integrin-dependent cell adhesion on vitronectin: The inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides

European Journal of Biochemistry

Volumn 253, Issue 3, 1998, Pages 669-674

  Germer, Matthias ^a   Kanse, Sandip M ^a   Kirkegaard, Tove ^b   Kjøller, Lars ^b   Felding Habermann, Brunhilde ^c   Goodman, Simon ^d   Preissner, Klaus T ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d MERCK KGAA   (Germany)

Author keywords

Cell adhesion; Plasminogen activator inhibitor 1; RGD peptide; Urokinase; Vitronectin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CELL SURFACE RECEPTOR; INTEGRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; UROKINASE; VITRONECTIN;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FAMILY; PROTEIN STABILITY;

EID: 0032079548     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2530669.x     Document Type: Article

References (45)

1. Bar-Shavit, R., Eskohjido, Y., Fenton, J. W. & Vlodansky, I. (1993) Thrombin adhesive properties: induction by plasmin and heparan sulfate, J. Cell Biol. 123, 1279-1287.
2. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell 79, 1157-1164.
3. 3, Cell 85, 683-693.
4. Carter, W. G., Rauvala, H. & Hakomori, S. I. (1981) Studies on cell adhesion and recognition. II. The kinetics of cell adhesion and cell spreading on surfaces coated with carbohydrate-reactive proteins (glycosidases and lectins) and fibronectin, J. Cell Biol. 88, 138-148.
5. Chavakis, T., Kanse, S. M., Yutzy, B., Lijnen, H. R. & Preissner, K. T. (1998) Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes, Blood 91, 2305-2312.
6. Choi, E. T., Engel, L., Callow, A. D., Sun, S., Trachtenberg, J., Santoro, S. & Ryan, U. S. (1994) Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with small peptide antagonist GpenGRGDSPCA, J. Vasc. Surg. 19, 125-134.
7. 2-macroglobulin receptor in human breast carcinomas, Int. J. Cancer 66, 441-452.
8. Ciambrone, G. J. & McKeown-Longo, P. J. (1990) Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells, J. Cell Biol, 111, 2183-2195.
9. Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Paques, E. P., Preissner, K. T., Müller-Berghaus, G. & Collen, D. (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin), J. Biol. Chem. 263, 15 454-15 461.
10. Deng, G., Curriden, S. A., Wang, S., Rosenberg, S. & Loskutoff, D. J. (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134, 1563-1571.
11. Ehrlich, H. J., Gebbink, R. K., Keijer, J, Linders, M., Preissner, K. T. & Pannekoek, H. (1990) Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties, J. Biol. Chem. 265, 13 029-13 035.
12. Fässler, R., Georges-Labouesse, E. & Hirsch, E. (1996) Genetic analysis of integrin function in mice, Curr. Opin. Cell Biol. 8, 641-646.
13. Frelinger, A. L., Cohen, I., Plow, E. F., Smith, M. A., Roberts, J., Lam, S. C. & Ginsberg, M. H. (1990) Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers, J. Biol. Chem. 265, 6346-6352.
14. 3 in ocular neovascular diseases, Proc. Natl Acad. Sci. USA 93, 9764-9769.
15. Goodman, S. L., Deutzmann, R. & von der Mark, K. (1987) Two distinct cell-binding domains in laminin can independently promote nonneuronal cell adhesion and spreading, J. Cell Biol. 105, 589-598.
16. Hammes, H. P., Brownlee, M., Jonczyk, A., Sutter, A. & Preissner, K. T. (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization, Nat. Med. 2, 529-533.
17. Howlett, A. R., Bailey, N., Damsky, C., Petersen, O. W. & Bissell, M. J. (1995) Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma, J. Cell Sci. 108, 1945-1957.
18. Humphries, M. J. (1990) The molecular basis and specificity of integrin-ligand interactions, J. Cell Sci, 97, 585-592.
19. Kanse, S. M., Kost, C., Wilhelm, O. G., Andreasen, P. A. & Preissner, K. T. (1996) The urokinase receptor is a major vitronectin-binding protein on endothelial cells, Exp. Cell Res. 224, 344-353.
20. Keijer, J., Linders, M., Ehrlich, H., Klein-Gebbink, R. & Pannekoek, H. (1990) Stabilisation of plasminogen activator inhibitor type 1 (PAI-1) acitivity by arginine: possible implications for the interaction of PAI-1 with vitronectin, Fibrinolysis 4, 153-159.
21. 2 macroglobulin receptor and urokinase receptor expression, Mol. Cell. Endocrinol. 109, 209-217.
22. Kjøller, L., Kanse, S. M., Kirkegaard, T., Rodenburg, K. W., Rönne, E., Goodman, S. L., Preissner, K. T. Ossowski, L. & Andreasen, P. A. (1997) Plasminogen activator inhihitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation, Exp. Cell Res. 232, 420-429.
23. Landegren, U. (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens, J. Immunol. Methods 67, 379-388.
24. Marguerie, G. A., Edgington, T. S. & Plow, E. F. (1980) Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation, J. Biol. Chem. 255, 154-161.
25. Marshall, J. F. & Hart, I. R. (1996) The role of α,-integrins in tumour progression and metastasis, Sem. Cancer Biol. 7, 129-138.
26. Meredith, J. E., Winitz, S., Lewis, J. M., Hess, S., Ren, X. D., Renshaw, M. W. & Schwartz, M. A. (1996) The regulation of growth and intracellular signaling by integrins, Endocrinol. Rev. 17, 207-220.
27. Mimuro, J. & Loskutoff, D. J. (1989) Purification of a protein from bovine plasma that binds to type I plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin, J. Biol. Chem. 264, 936-939.
28. Mitjans, F., Sander, D., Adan, J., Sutter, A., Martinez, J. M., Jaggle, C. S., Moyano, J. M., Kreysch, H. G., Piulats, J. & Goodman, S. L. (1995) An anti-α,-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice, J. Cell Sci. 108, 2825-2838.
29. Munch, M., Heegaard, C. W. & Andreasen, P. A. (1993) Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor, Biochem. Biophys. Acta 1202, 29-37.
30. Nielsen, L. S., Grøndahl-Hansen, J., Andreasen, P. A., Skriver, L., Zeuthen, J. & Danø, K. (1986) Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies, J. Immunoassay 7, 209-228.
31. 3 and its ligand, J. Biol. Chem. 266, 19 543-19 550.
32. 3 integrin involved in adhesion of leukocytes to endothelium, J. Cell Biol. 130, 451-460.
33. Pöllänen, J., Saksela, O., Salonen, E. M., Andreasen, P., Nielsen, L., Danø, K. & Vaheri, A. (1987) Distinct localizations of urokinase-type plasminogen activator and its type I inhibitor under cultured human fibroblasts and sarcoma cells, J. Cell Biol. 104, 1085-1096.
34. Preissner, K. T., Wassmuth, R. & Müller-Berghaus, G. (1985) Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem. J. 231, 349-355.
35. Sakata, Y., Okada, M., Noro, A. & Matsuda, M. (1988) Interaction of tissue-type plasmiogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells, J. Biol. Chem. 263, 1960-1969.
36. Salonen, E. M., Vaheri, A., Pöllänen, J., Stephens, R., Andreasen, P., Mayor, M., Danø, K., Gailit, J. & Ruoslahti, E. (1989) Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin, J. Biol. Chem. 264, 6339-6343.
37. Ständker, L., Enger, A., Schulz-Knappe, P., Wohn, K. D., Germer, M., Raida, M., Forssmann, W. G. & Preissner, K. T. (1996) Structural and functional characterization of vitronectin-derived RGD-containing peptides from human hemofiltrate, Eur. J. Biochem. 241, 557-563.
38. 3 binding to vitronectin, Nature 383, 441-443.
39. Stockmann, A., Hess, S., Declerck, P., Timpl, R. & Preissner, K. T. (1993) Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein, J. Biol. Chem. 268, 22 874-22 882.
40. Ugarova, T. P., Budzynski, A. Z., Shattil, S. J., Ruggeri, Z. M., Ginsberg, M. H. & Plow, E. F. (1993) Conformational changes in fibrinogen elicited by its interaction with platelet membrane glycoprotein GPIIb-IIIa, J. Biol. Chem. 268, 21 080-21 087.
41. Waltz, D. A. & Chapman, H. A. (1994) Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy, J. Biol. Chem. 269, 14 746-14 750.
42. Waltz, D. A., Natkin, L. R., Fujita, R. M., Wei, Y. & Chapman, H. A. (1997) Plasmin and plasminogen activator inhibitor type I promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin, J. Clin. Invest. 100, 58-67.
43. Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S. & Chapman, H. A. (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin, J. Biol. Chem. 269, 32 380-32 388.
44. Wun, T. C., Palmier, M. O., Siegel, N. R. & Smith, C. E. (1989) Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin, J. Biol. Chem. 264, 7862-7868.
45. Yatohgo, T., Izumi, M., Kashiwagi, H. & Hayashi, M. (1988) Novel purification of vitronectin from human plasma by heparin affinity chromatography, Cell. Struct. Funct. 13, 281-292.